Add like
Add dislike
Add to saved papers

Objective measure of bradykinesia in parkinsonism by the maximal frequency of standardized, large pronation/supination movements.

OBJECTIVE: Bradykinesia in Parkinson's disease (PD) predominates in large movements. Traditional assessments use the UPDRS, a subjective and ordinal tool that does not rate movement scaling (hypometria). We have measured the maximum frequency of standardized large alternating elbow pronation/supination movements in patients with PD, hypothesizing a negative correlation with the UPDRS III score and with the delay since diagnosis.

MATERIALS/PATIENTS AND METHODS: We carried out a retrospective study on a convenience sample of 30 patients with idiopathic PD from Henri Mondor University Hospitals (Créteil, France), all assessed in the clinically defined OFF state by a single rater. Assessment included the maximal frequency of large (180°C) elbow pronation/supination movements (FLM), bilaterally, using a portable tool. Patients were also assessed on UPDRS III and bradykinesia sub-scores (UPDRS IIIb). We explored correlations (Pearson) between FLM and UPDRS III, UPDRS IIIb and time since diagnosis (TSD).

RESULTS: UPDRS III was 20.08±10.0 (mean±SD), TSD was 9.9±5.2 years and FLM were 0.75±0.27Hz and 0.94±0.25 on the more and less affected side respectively (strongly correlated with each other, r=0.80, p<0.0001). Correlations with UPDRS III scores and time since diagnosis for the more affected arm (resp less affected arm) were as follows FLM-UPDRSIII: r=-0.28; p=0.15 (r=-0.40; p=0.04); RLM-UPDRSIIIB, r=-0.48; p=0.01 (r=-0.36; p=0.06); FLM-TSD, r=-0.36; p=0.07 (r=-0.51; p=0.007).

DISCUSSION/CONCLUSION: These findings validate the maximal frequency of standardized 180°C pronation/supination movements as a clinical marker of the severity of parkinsonism. Intra- and inter-rater reliability and sensitivity to change of FLM still need to be investigated. FLM is easily usable in the clinic setting and might become a useful tool to optimize the monitoring of treatment effects and patient evolution.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app